Pictured are Stephanie Lee, MD (right), a long-time patient, who brought her friend Soo Han, MD.
Stephanie, who has tried Botox and Dysport previously, came in for a neurotoxin treatment. I asked if she had heard about Jeuveau. After I shared the story of the newest toxin to be introduced in nearly a decade, she wanted to be my first patient.
I told her what I learned at the physician advisory meeting* earlier this month. Jeuveau is made in Korea exclusively for Evolus and it is distributed by Evolus in the USA.
Both ladies were excited to try something new. They also mentioned that people in Korea are much more likely to start toxin treatments in their 20s, so this new approach to marketing to the young is the way to go.
*it was in Cancun and travel expenses were paid by Evolus